APO RESEARCH · REPORT
Organoids
Organoids are in-vitro derived 3D cell aggregates derived from primary tissue or stem cells that are capable of self-renewal, self-organization and exhibit organ functionality. Organoids address the limitations of existing model systems by providing:
Product & engineering
Understand the product.
Organoids are in-vitro derived 3D cell aggregates derived from primary tissue or stem cells that are capable of self-renewal, self-organization and exhibit organ functionality. Organoids address the limitations of existing model systems by providing:
Similar composition and architecture to primary tissue: Organoids harbor small population of self-renewing stem cells that can differentiate into cells of all major cell lineages, with similar frequency as in physiological condition.
Relevant models of in-vivo conditions: Organoids are more biologically relevant to any model system and are amenable to manipulate niche components and gene sequence.
Stable system for extended cultivation: Organoids can be cryopreserved as biobanks and expanded indefinitely by leveraging self-renewal, differentiation capability of stem cell and intrinsic ability to self-organize.
Selected research
Industry Growth & Trends
Global Organoids Industry Growth and Trends Forecast to 2032
Market perspective
Organoids are in-vitro derived 3D cell aggregates derived from primary tissue or stem cells that are capable of self-renewal, self-organization and exhibit organ functionality. Organoids address the limitations of existing model systems by providing:
Similar composition and architecture to primary tissue: Organoids harbor small population of self-renewing stem cells that can differentiate into cells of all major cell lineages, with similar frequency as in physiological condition.
Relevant models of in-vivo conditions: Organoids are more biologically relevant to any model system and are amenable to manipulate niche components and gene sequence.
Read the full market overview
Stable system for extended cultivation: Organoids can be cryopreserved as biobanks and expanded indefinitely by leveraging self-renewal, differentiation capability of stem cell and intrinsic ability to self-organize.
According to APO Research, the global Organoids market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
This report provides a structured, data-driven view of the global Organoids market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Organoids market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Organoids market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Organoids.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Organoids market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Organoids Market by Company
Thermo Fisher Scientific
Merck
Corning
STEMCELL Technologies
Lonza
Prellis Biologics
amsbio
Cellesce
DefiniGEN
OcellO B.V.
HUB Oranoid Technology
3Dnamics Inc.
Organoid Therapeutics
InSphero
Organoids Segment by Type
3D Organoid Culture
Biochemical Cues
Organoids Segment by Application
Biopharmaceutical Companies
Contract Research Organizations
Academics and Research Institutes
Organoids Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Organoids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Organoids and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Organoids.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Organoids companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 3D Organoid Culture
- Biochemical Cues
Applications
- Biopharmaceutical Companies
- Contract Research Organizations
- Academics and Research Institutes
Companies covered
- Thermo Fisher Scientific
- Merck
- Corning
- STEMCELL Technologies
- Lonza
- Prellis Biologics
- amsbio
- Cellesce
- DefiniGEN
- OcellO B.V.
- HUB Oranoid Technology
- 3Dnamics Inc.
- Organoid Therapeutics
- InSphero
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Organoids Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Organoids Market Size by Region (2021-2032)
- 1.4.1 Global Organoids Market Size by Region (2021-2026)
- 1.4.2 Global Organoids Market Size by Region (2027-2032)
- 1.5 Key Regions Organoids Market Size (2021-2032)
- 1.5.1 North America Organoids Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Organoids Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Organoids Market Size Growth Rate (2021-2032)
- 1.5.4 South America Organoids Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Organoids Market Size Growth Rate (2021-2032)
2 Organoids Market by Type
- 2.1 Type Introduction
- 2.1.1 3D Organoid Culture
- 2.1.2 Biochemical Cues
- 2.2 Global Organoids Market Size by Type
- 2.2.1 Global Organoids Market Size Overview by Type (2021-2032)
- 2.2.2 Global Organoids Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Organoids Market Size Forecasted by Type (2027-2032)
- 2.3 Global Organoids Market Size by Regions
- 2.3.1 North America Organoids Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Organoids Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Organoids Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Organoids Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Organoids Market Size Breakdown by Type (2021-2026)
3 Organoids Market by Application
- 3.1 Type Introduction
- 3.1.1 Biopharmaceutical Companies
- 3.1.2 Contract Research Organizations
- 3.1.3 Academics and Research Institutes
- 3.2 Global Organoids Market Size by Application
- 3.2.1 Global Organoids Market Size Overview by Application (2021-2032)
- 3.2.2 Global Organoids Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Organoids Market Size Forecasted by Application (2027-2032)
- 3.3 Global Organoids Market Size by Regions
- 3.3.1 North America Organoids Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Organoids Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Organoids Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Organoids Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Organoids Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Organoids Industry Trends
- 4.2 Organoids Industry Drivers
- 4.3 Organoids Industry Opportunities and Challenges
- 4.4 Organoids Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Organoids Revenue (2021-2026)
- 5.2 Global Organoids Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Organoids Key Company Headquarters & Area Served
- 5.4 Global Organoids Company, Product Type & Application
- 5.5 Global Organoids Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Organoids Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Organoids Players Market Share by Revenue in 2025
- 5.6.3 2025 Organoids Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Thermo Fisher Scientific
- 6.1.1 Thermo Fisher Scientific Company Information
- 6.1.2 Thermo Fisher Scientific Business Overview
- 6.1.3 Thermo Fisher Scientific Organoids Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Thermo Fisher Scientific Organoids Product Portfolio
- 6.1.5 Thermo Fisher Scientific Recent Developments
- 6.2 Merck
- 6.2.1 Merck Company Information
- 6.2.2 Merck Business Overview
- 6.2.3 Merck Organoids Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Merck Organoids Product Portfolio
- 6.2.5 Merck Recent Developments
- 6.3 Corning
- 6.3.1 Corning Company Information
- 6.3.2 Corning Business Overview
- 6.3.3 Corning Organoids Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Corning Organoids Product Portfolio
- 6.3.5 Corning Recent Developments
- 6.4 STEMCELL Technologies
- 6.4.1 STEMCELL Technologies Company Information
- 6.4.2 STEMCELL Technologies Business Overview
- 6.4.3 STEMCELL Technologies Organoids Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 STEMCELL Technologies Organoids Product Portfolio
- 6.4.5 STEMCELL Technologies Recent Developments
- 6.5 Lonza
- 6.5.1 Lonza Company Information
- 6.5.2 Lonza Business Overview
- 6.5.3 Lonza Organoids Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Lonza Organoids Product Portfolio
- 6.5.5 Lonza Recent Developments
- 6.6 Prellis Biologics
- 6.6.1 Prellis Biologics Company Information
- 6.6.2 Prellis Biologics Business Overview
- 6.6.3 Prellis Biologics Organoids Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Prellis Biologics Organoids Product Portfolio
- 6.6.5 Prellis Biologics Recent Developments
- 6.7 amsbio
- 6.7.1 amsbio Company Information
- 6.7.2 amsbio Business Overview
- 6.7.3 amsbio Organoids Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 amsbio Organoids Product Portfolio
- 6.7.5 amsbio Recent Developments
- 6.8 Cellesce
- 6.8.1 Cellesce Company Information
- 6.8.2 Cellesce Business Overview
- 6.8.3 Cellesce Organoids Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Cellesce Organoids Product Portfolio
- 6.8.5 Cellesce Recent Developments
- 6.9 DefiniGEN
- 6.9.1 DefiniGEN Company Information
- 6.9.2 DefiniGEN Business Overview
- 6.9.3 DefiniGEN Organoids Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 DefiniGEN Organoids Product Portfolio
- 6.9.5 DefiniGEN Recent Developments
- 6.10 OcellO B.V.
- 6.10.1 OcellO B.V. Company Information
- 6.10.2 OcellO B.V. Business Overview
- 6.10.3 OcellO B.V. Organoids Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 OcellO B.V. Organoids Product Portfolio
- 6.10.5 OcellO B.V. Recent Developments
- 6.11 HUB Oranoid Technology
- 6.11.1 HUB Oranoid Technology Company Information
- 6.11.2 HUB Oranoid Technology Business Overview
- 6.11.3 HUB Oranoid Technology Organoids Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 HUB Oranoid Technology Organoids Product Portfolio
- 6.11.5 HUB Oranoid Technology Recent Developments
- 6.12 3Dnamics Inc.
- 6.12.1 3Dnamics Inc. Company Information
- 6.12.2 3Dnamics Inc. Business Overview
- 6.12.3 3Dnamics Inc. Organoids Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 3Dnamics Inc. Organoids Product Portfolio
- 6.12.5 3Dnamics Inc. Recent Developments
- 6.13 Organoid Therapeutics
- 6.13.1 Organoid Therapeutics Company Information
- 6.13.2 Organoid Therapeutics Business Overview
- 6.13.3 Organoid Therapeutics Organoids Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Organoid Therapeutics Organoids Product Portfolio
- 6.13.5 Organoid Therapeutics Recent Developments
- 6.14 InSphero
- 6.14.1 InSphero Company Information
- 6.14.2 InSphero Business Overview
- 6.14.3 InSphero Organoids Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 InSphero Organoids Product Portfolio
- 6.14.5 InSphero Recent Developments
7 North America
- 7.1 North America Organoids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Organoids Market Size by Country (2021-2026)
- 7.3 North America Organoids Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Organoids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Organoids Market Size by Country (2021-2026)
- 8.3 Europe Organoids Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Organoids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Organoids Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Organoids Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Organoids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Organoids Market Size by Country (2021-2026)
- 10.3 South America Organoids Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Organoids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Organoids Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Organoids Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst